Market Overview

46 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

  • American Electric Technologies, Inc (NASDAQ: AETI) shares jumped 187.4 percent to $1.15 after the company disclosed that its joint venture, BOMAY, received a major order for drilling rig control systems.
  • TESARO Inc (NASDAQ: TSRO) surged 58.8 percent to $73.64 after GlaxoSmithKline plc (NYSE: GSK) announced plans to acquire the company for $75 per share in cash.
  • Borqs Technologies, Inc. (NASDAQ: BRQS) gained 33.7 percent to $7.62.
  • Global Blood Therapeutics, Inc. (NASDAQ: GBT) shares climbed 29.2 percent to $40.74. Global Blood announced Monday that the FDA has agreed to allow filing for its late-stage sickle cell disease, or SCD, candidate Voxelotor under an accelerated approval pathway. The company said it would submit a new drug application, or NDA, for the pipeline asset under the pathway.
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares gained 16.5 percent to $29.16 after the company's phase 2 study of Tradipitant met its primary endpoint and most secondary endpoints.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) rose 15.4 percent to $19.86.
  • Biohaven Pharmaceutical Holding Company Ltd. (NASDAQ: BHVN) gained 15.4 percent to $39.22 after reporting positive Phase 3 results with rimegepant zydis orally dissolving tablet for the acute treatment of migraine.
  • Osmotica Pharmaceuticals plc (NASDAQ: OSMT) climbed 12.7 percent to $8.88.
  • Karyopharm Therapeutics Inc. (NASDAQ: KPTI) rose 12.6 percent to $11.71 after reporting positive top-line Phase 2b SADAL data for selinexor in patients with diffuse large B-cell lymphoma at the American Society of Hematology 2018 Annual Meeting.
  • argenx SE (NASDAQ: ARGX) rose 12.2 percent to $108.57 after Janssen affiliate Cilag GmbH International disclosed a worldwide collaboration and license agreement with Argenx for cancer immunotherapy cusatuzumab.
  • CASI Pharmaceuticals, Inc. (NASDAQ: CASI) gained 11.3 percent to $4.82 after reporting China market approval of Melphalan Hydrochloride for injection.
  • Laredo Petroleum, Inc. (NYSE: LPI) climbed 11.3 percent to $4.86.
  • Wynn Resorts, Limited (NASDAQ: WYNN) rose 10.4 percent to $120.80.
  • Tribune Media Company (NYSE: TRCO) rose 9.9 percent to $44.255 after Nexstar Media Group Inc (NASDAQ: NXST) announced plans to acquire the company for $46.50 per share.
  • Karyopharm Therapeutics Inc. (NASDAQ: KPTI) shares climbed 9.6 percent to $11.40.
  • Crescent Point Energy Corp. (NYSE: CPG) gained 9.4 percent to $3.24.
  • Cenovus Energy Inc. (NYSE: CVE) shares jumped 9 percent to $8.04.
  • Chart Industries, Inc. (NASDAQ: GTLS) rose 8.3 percent to $68.830. Evercore ISI Group upgraded Chart Industries from In-Line to Outperform.
  • China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 8 percent to $1.76.
  • ZAGG Inc (NASDAQ: ZAGG) gained 7.8 percent to $10.83.
  • The Timken Company (NYSE: TKR) climbed 6.6 percent to $42.80. Bank of America upgraded Timken from Neutral to Buy.
  • Seadrill Limited (NYSE: SDRL) shares rose 6.5 percent to $14.520 after dropping 7.40 percent on Friday.
  • CLPS Incorporation (NASDAQ: CLPS) gained 6.5 percent to $5.88.
  • RadiSys Corporation (NASDAQ: RSYS) rose 6.2 percent to $1.71 after the company reported the CFIUS clearance related to its acquisition of Reliance Industries.
  • Noodles & Company (NASDAQ: NDLS) climbed 6.2 percent to $8.40. RBC Capital upgraded Noodles & Co from Sector Perform to Outperform.
  • New Age Beverages Corporation (NASDAQ: NBEV) rose 6.1 percent to $4.91 after the company announced plans to acquire Morinda Holdings, Inc. for $75 million in cash and $10 million in stock.

 

Check out these big penny stock gainers and losers

Losers

  • Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) shares tumbled 30.7 percent to $7.01 after reporting top-line results from a Phase 2b study of SNA-120.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares fell 25.8 percent to $3.85 after the company filed for a $34M stock and warrant offering.
  • Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) fell 23.3 percent to $2.9465 after rising 37.14 percent on Friday.
  • Hexindai Inc. (NASDAQ: HX) shares dropped 19.7 percent to $3.54 following Q2 results. Hexindai posted a Q2 loss of $0.36 per share on sales of $3.62 million.
  • Aphria Inc. (NYSE: APHA) declined 19.6 percent to $6.35 after Reuters reported that 2 research firms issued negative reports on the stock.
  • Tel-Instrument Electronics Corp. (NYSE: TIK) fell 19.5 percent to $3.1155 after surging 57.96 percent on Friday.
  • Sphere 3D Corp. (NASDAQ: ANY) dropped 13.7 percent to $4.54.
  • UTStarcom Holdings Corp. (NASDAQ: UTSI) shares declined 12.4 percent to $3.1269.
  • Realm Therapeutics Plc (NASDAQ: RLM) shares tumbled 11.7 percent to $2.63.
  • Xcel Brands, Inc. (NASDAQ: XELB) fell 11.5 percent to $1.8313.
  • Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) dropped 11.4 percent to $1.87.
  • Arlo Technologies, Inc. (NYSE: ARLO) shares declined 11.4 percent to $10.65. Arlo Technologies expects Q4 sales of $125 million to $130 million.
  • Centrus Energy Corp. (NYSE: LEU) shares fell 10.6 percent to $2.5037.
  • Magenta Therapeutics, Inc. (NASDAQ: MGTA) dropped 10 percent to $8.80.
  • Trillium Therapeutics Inc. (NASDAQ: TRIL) fell 9.6 percent to $2.72 following an update on its intratumoral TTI-621 program at the American Society of Hematology 60th Annual Meeting.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) dropped 9.6 percent to $6.02. Cantor Fitzgerald reiterated Overweight rating on Ocular Therapeutics following the FDA approval of DEXTENZA.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) fell 8.1 percent to $3.9889 after highlighting results from Phase 2 trial of oral rigosertib in combination with azacitidine in myelodysplastic syndromes at 2018 ASH Annual Meeting.
  • Alliqua BioMedical, Inc. (NASDAQ: ALQA) shares dipped 7.8 percent to $2.5440.
  • bluebird bio, Inc. (NASDAQ: BLUE) fell 7.2 percent to $114.03. bluebird bio and Celgene Corporation (NASDAQ: CELG) presented initial Phase 1 data for multiple myeloma treatment candidate bb21217 at ASH 2018.
  • Xenetic Biosciences, Inc. (NASDAQ: XBIO) dipped 6.8 percent to $3.075.

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

 

Related Articles (AETI + ADIL)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Altria Reportedly In Talks To Buy Cronos Group

Cannabis Consumer Report Highlights Potential Displacement Of Alcohol